| Blumgart anastomosis for pancreaticojejunostomy minimizes severe complications after pancreatic head resection A Kleespies, M Rentsch, H Seeliger, M Albertsmeier, KW Jauch, CJ Bruns Journal of British Surgery 96 (7), 741-750, 2009 | 206 | 2009 |
| Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF M Guba, M Yezhelyev, ME Eichhorn, G Schmid, I Ischenko, A Papyan, ... Blood 105 (11), 4463-4469, 2005 | 182 | 2005 |
| The challenge of pancreatic anastomosis A Kleespies, M Albertsmeier, F Obeidat, H Seeliger, KW Jauch, CJ Bruns Langenbeck's Archives of Surgery 393, 459-471, 2008 | 176 | 2008 |
| Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis H Seeliger, M Guba, A Kleespies, KW Jauch, CJ Bruns Cancer and Metastasis Reviews 26, 611-621, 2007 | 152 | 2007 |
| Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer CJ Bruns, GE Koehl, M Guba, M Yezhelyev, M Steinbauer, H Seeliger, ... Clinical cancer research 10 (6), 2109-2119, 2004 | 147 | 2004 |
| Cancer stem cells: how can we target them? I Ischenko, H Seeliger, M Schaffer, KW Jauch, CJ Bruns Current medicinal chemistry 15 (30), 3171-3184, 2008 | 145 | 2008 |
| Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer A Kleespies, KE Füessl, H Seeliger, ME Eichhorn, MH Müller, M Rentsch, ... International journal of colorectal disease 24, 1097-1109, 2009 | 132 | 2009 |
| Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. GF Scheumann, H Seeliger, TJ Musholt, O Gimm, G Wegener, H Dralle, ... The European Journal of Surgery= Acta Chirurgica 162 (9), 677-684, 1996 | 125 | 1996 |
| EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma H Seeliger, P Camaj, I Ischenko, A Kleespies, EN De Toni, SE Thieme, ... Molecular Cancer Research 7 (2), 189-198, 2009 | 124 | 2009 |
| Risk factors for surgical complications in distal pancreatectomy H Seeliger, S Christians, MK Angele, A Kleespies, ME Eichhorn, ... The American journal of surgery 200 (3), 311-317, 2010 | 115 | 2010 |
| Vascular endothelial growth factor in colorectal cancer M Guba, H Seeliger, A Kleespies, KW Jauch, C Bruns International journal of colorectal disease 19, 510-517, 2004 | 115 | 2004 |
| Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation MS Exton, S von Hörsten, M Schult, J Vöge, T Strubel, S Donath, ... Journal of neuroimmunology 88 (1-2), 182-191, 1998 | 98 | 1998 |
| EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells P Camaj, H Seeliger, I Ischenko, S Krebs, H Blum, EN De Toni, ... Walter de Gruyter 390 (12), 1293-1302, 2009 | 97 | 2009 |
| Laparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies K Beyer, AK Baukloh, C Kamphues, H Seeliger, CD Heidecke, ME Kreis, ... World journal of surgical oncology 17, 1-19, 2019 | 93 | 2019 |
| Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling I Ischenko, P Camaj, H Seeliger, A Kleespies, M Guba, EN De Toni, ... Oncogene 27 (57), 7212-7222, 2008 | 87 | 2008 |
| Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil … H Seeliger, M Guba, GE Koehl, A Doenecke, M Steinbauer, CJ Bruns, ... Clinical cancer research 10 (5), 1843-1852, 2004 | 83 | 2004 |
| Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications I Ischenko, H Seeliger, A Kleespies, MK Angele, ME Eichhorn, KW Jauch, ... Langenbeck's archives of surgery 395, 1-10, 2010 | 61 | 2010 |
| Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma C Schäfer, H Seeliger, DC Bader, G Assmann, D Buchner, Y Guo, ... Journal of cellular and molecular medicine 16 (8), 1776-1791, 2012 | 52 | 2012 |
| Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery E Gallmeier, DC Bader, L Kriegl, S Berezowska, H Seeliger, B Göke, ... PloS one 8 (2), e56760, 2013 | 39 | 2013 |
| Minimal residual disease in gastric cancer H Seeliger, H Spatz, KW Jauch Molecular Staging of Cancer, 79-87, 2003 | 38 | 2003 |
Prof. Dr. med. Markus GubaChirurgische Klinik, Klinikum Großhadern, Universität MünchenVerified email at med.uni-muenchen.de
